Haiyang Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Haiyang Liu has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Hongjia Pan
Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, China
3 shared publicationsPengpeng Min
Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, China
2 shared publications- Xi Li
Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, China
2 shared publications Yunsong Yu
Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, 310014, China; Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, 310016, China
2 shared publications- Yunsong Yu
Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine
2 shared publications Chongmei Tian
Department of Pharmacy, Shaoxing Hospital of Traditional Chinese Medicine Affiliated to Zhejiang Chinese Medical University, Shaoxing, China
1 shared publication
Latest Publications
- Open Access
- 30 September 2026
- Published by Springer Nature in npj Antimicrobials and Resistance
Emerging clinical threat of NDM-producing Acinetobacter soli in China: a multicentre retrospective genomic epidemiology study
- 30 September 2026
- Published by Springer Nature in npj Antimicrobials and Resistance
Open AccessEmerging clinical threat of NDM-producing Acinetobacter soli in China: a multicentre retrospective genomic epidemiology study
- Open Access
- 21 June 2026
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 50, 84-90
Global Epidemiological Survey and Genomic Analysis of Multiple Carbapenemases-Producing Citrobacter freundii
- 21 June 2026
- Published by Elsevier in Journal of Global Antimicrobial Resistance
- Vol. 50, 84-90
Open AccessGlobal Epidemiological Survey and Genomic Analysis of Multiple Carbapenemases-Producing Citrobacter freundii
- Open Access
- 25 May 2026
- Published by Springer Nature in BMC Microbiology
- Vol. 26 (1)
Genomic and phenotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from patients and trolleys and their potential connections in an intensive care unit
Carbapenem-resistant Acinetobacter baumannii (CRAB) poses significant challenges in intensive care units (ICU) due to its multidrug resistance and environmental persistence. To date, most studies have focused on clinical isolates or patient-environment transmission. However, high-touch mobile surfaces have been less extensively characterized. We collected 49 CRAB isolates in 2019 and 2021 from ICU patients (n = 32) and trolley surfaces (n = 17). 91.84% (45/49) isolates belonged to ST2Pas and carried blaOXA-23. The capsular polysaccharide (K locus) and lipopolysaccharide (OC locus) types were predominantly KL7 and OCL1, respectively. Comparative genomic analysis revealed a high degree of genomic relatedness between patient and trolley associated isolates, including three clonal clusters (SNP differences < 19). To further characterize environmental persistence, we assessed biofilm formation using Live/Dead staining and scanning electron microscopy (SEM), and evaluated disinfectant susceptibility across all isolates. These findings demonstrate the coexistence of closely related CRAB on patients and trolley surfaces within the same ICU and highlight the importance of considering high-touch mobile surfaces in infection prevention and control (IPC) strategies. ClinicalTrials.gov, NCT04310722. Registered on 18 March 2020. Retrospectively registered.
- 25 May 2026
- Published by Springer Nature in BMC Microbiology
- Vol. 26 (1)
Open AccessGenomic and phenotypic characterization of carbapenem-resistant Acinetobacter baumannii isolates from patients and trolleys and their potential connections in an intensive care unit
Carbapenem-resistant Acinetobacter baumannii (CRAB) poses significant challenges in intensive care units (ICU) due to its multidrug resistance and environmental persistence. To date, most studies have focused on clinical isolates or patient-environment transmission. However, high-touch mobile surfaces have been less extensively characterized. We collected 49 CRAB isolates in 2019 and 2021 from ICU patients (n = 32) and trolley surfaces (n = 17). 91.84% (45/49) isolates belonged to ST2Pas and carried blaOXA-23. The capsular polysaccharide (K locus) and lipopolysaccharide (OC locus) types were predominantly KL7 and OCL1, respectively. Comparative genomic analysis revealed a high degree of genomic relatedness between patient and trolley associated isolates, including three clonal clusters (SNP differences < 19). To further characterize environmental persistence, we assessed biofilm formation using Live/Dead staining and scanning electron microscopy (SEM), and evaluated disinfectant susceptibility across all isolates. These findings demonstrate the coexistence of closely related CRAB on patients and trolley surfaces within the same ICU and highlight the importance of considering high-touch mobile surfaces in infection prevention and control (IPC) strategies. ClinicalTrials.gov, NCT04310722. Registered on 18 March 2020. Retrospectively registered.
- Open Access
- 16 February 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (2) , 396
Emergence and Evolution of OXA-23-Producing ST46Pas-ST462Oxf-KL28-OCL1 Carbapenem-Resistant Acinetobacter baumannii Mediated by a Novel ISAba1-Based Tn7534 Transposon
Carbapenem-resistant Acinetobacter baumannii (CRAB) isolates of global clone 1 (GC1) and global clone 2 (GC2) have been widely reported. Nevertheless, non-GC1 and non-GC2 CRAB strains have been studied less. In particular, no reports concerning sequence type 46 (ST46Pas) CRAB strains have been described thus far. In this work, the genomic features and possible evolution mechanism of ST46Pas OXA-23-producing CRAB isolates from clinical specimens are reported for the first time. Antimicrobial susceptibility testing of three ST46Pas strains revealed identical resistance profiles (resistance to imipenem, meropenem, ciprofloxacin and the combination of cefoperazone/sulbactam at a 2:1 ratio). They were found to belong to ST46Pas and ST462Oxf with capsular polysaccharide 28 (KL28) and lipooligosaccharide 1 (OCL1), respectively. Whole-genome sequencing (WGS) revealed that all contained one copy of chromosomal blaOXA-23, which was located in a novel ISAba1-based Tn7534 composite transposon. In particular, another copy of the Tn7534 composite transposon was identified in an Hgz_103-type plasmid with 9 bp target site duplications (TSDs, ACAACATGC) in the A. baumannii ZHOU strain. As the strains originated from two neighboring intensive care units (ICUs), ST46Pas OXA-23-producing CRAB strains may have evolved via transposition events or a pdif module. Based on the GenBank database, ST46Pas strains were collected from various sources; however, most were collected in Hangzhou (China) from 2014 to 2021. Pan-genome analysis revealed 3276 core genes, 0 soft-core genes, 768 shell genes and 443 cloud genes shared among all ST46Pas strains. In conclusion, the emergence of ST46Pas CRAB strains might present a new threat to healthcare settings; therefore, effective surveillance is required to prevent further dissemination.
- 16 February 2023
- Published by MDPI AG in Antibiotics
- Vol. 12 (2) , 396
Open AccessEmergence and Evolution of OXA-23-Producing ST46Pas-ST462Oxf-KL28-OCL1 Carbapenem-Resistant Acinetobacter baumannii Mediated by a Novel ISAba1-Based Tn7534 Transposon
Carbapenem-resistant Acinetobacter baumannii (CRAB) isolates of global clone 1 (GC1) and global clone 2 (GC2) have been widely reported. Nevertheless, non-GC1 and non-GC2 CRAB strains have been studied less. In particular, no reports concerning sequence type 46 (ST46Pas) CRAB strains have been described thus far. In this work, the genomic features and possible evolution mechanism of ST46Pas OXA-23-producing CRAB isolates from clinical specimens are reported for the first time. Antimicrobial susceptibility testing of three ST46Pas strains revealed identical resistance profiles (resistance to imipenem, meropenem, ciprofloxacin and the combination of cefoperazone/sulbactam at a 2:1 ratio). They were found to belong to ST46Pas and ST462Oxf with capsular polysaccharide 28 (KL28) and lipooligosaccharide 1 (OCL1), respectively. Whole-genome sequencing (WGS) revealed that all contained one copy of chromosomal blaOXA-23, which was located in a novel ISAba1-based Tn7534 composite transposon. In particular, another copy of the Tn7534 composite transposon was identified in an Hgz_103-type plasmid with 9 bp target site duplications (TSDs, ACAACATGC) in the A. baumannii ZHOU strain. As the strains originated from two neighboring intensive care units (ICUs), ST46Pas OXA-23-producing CRAB strains may have evolved via transposition events or a pdif module. Based on the GenBank database, ST46Pas strains were collected from various sources; however, most were collected in Hangzhou (China) from 2014 to 2021. Pan-genome analysis revealed 3276 core genes, 0 soft-core genes, 768 shell genes and 443 cloud genes shared among all ST46Pas strains. In conclusion, the emergence of ST46Pas CRAB strains might present a new threat to healthcare settings; therefore, effective surveillance is required to prevent further dissemination.